Dutch consortium investigates biomarker to identify early-stage melanoma at high-risk of recurrence
Today, SkylineDx announced a research collaboration with an academic hospital and a Dutch cancer registry to investigate patients with early-stage melanoma (skin cancer) at high risk of disease-related fatality.